IgM/IgG Rapid Tests

Delivering A Robust Methodology To Test and Treat Every
Case In Order To Break The Chains of Transmission

A Smarter Strategy To Move Past The CoV-19 Pandemic

When Serology Antibody Testing is adequately planned and routinized, the methodology is likely to lead to an effective scaled approach for Critical and General COVID-19 population screening: the basis of our Rapid Testing strategy is the finger-stick testing modality with IgG/IgM test kits.
By using bio-markers from the body’s immune response to COVID-19 instead of looking for the virus itself, COVID-19 IgM/IgG Test can help determine if a person has been infected with the corona virus even after the virus is no longer present. This information helps experts understand how the virus spreads through populations. It also improves our strategic approach to control the continued spread of the pandemic.

The sheer speed of our Rapid Test and turn-around time presents the most immediately impactful benefit of POCT in unleashing the power of a fast action 4-10 minute identification of the infected Patient.

IgM/IgG Antibody Testing tells us if an individual has been infected with the virus. This is vital in managing the spread of further infections. Such data is also critical to knowing how deadly the actual infection can be. Through our capacity to collect data, we are more informed about the efficacy of preventative measures and can determine the risks of disease to ascertain in-depth data on population risk stratification and mortality rates.
2 Powerful Rapid Test Kits. Same Accuracy.
1 Sample Well Or 2 Sample Wells. Your Choice

FDA Emergency Use Authorized

Rapid serology test for the qualitative detection of SARS-CoV-2 IgG and IgM antibodies in venous whole blood, serum and plasma

SARS-CoV-2 total antibody rapid Test. Intended for screening of patients suspected of COVID-19 infection. Lateral Flow Test – suitable for rapid, on-site testing. Performance: sensitivity of 94.70% (125/132) and specificity of 98.89% (268/271). The test has been clinically validated during the 2020 COVID-19 outbreak in China.

Easy-to-use: No special equipment. Works with whole blood, serum or plasma samples Fast: Clear answer within only 15 minutes.